Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL654697 | 0.87 | — | — | |
| Sulfuric Acid SCHEMBL5671172 | 0.82 | NT5E (0.31) | MAPTTDP1 | |
| Sulfuric Acid SCHEMBL5672040 | 0.82 | NT5E (0.31) | — | |
| SCHEMBL29242712 | 0.78 | MAPT (0.38) | MAPTTDP1HRH4HRH3MEN1 | |
| Sulfuric Acid SCHEMBL11468643 | 0.77 | CA12 (0.38) | CA12CA1CA2CA9MAPT | |
| Sulfuric Acid SCHEMBL6484423 | 0.75 | CA12 (0.37) | CA12CA1CA2CA9MAPT | |
| SCHEMBL6898924 | 0.74 | — | — | |
| SCHEMBL8625405 | 0.72 | CA12 (0.38) | CA12CA1CA2CA9MAPT | |
| Sulfuric Acid SCHEMBL3344978 | 0.71 | CA5A (0.43) | CA12CA1CA2CA9MAPT | |
| Sulfuric Acid SCHEMBL129071 | 0.71 | CA5A (0.43) | CA12CA1CA2CA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024059615-A2 | SUSTAINED-RELEASE SCALE INHIBITORS | MATERIALS ENGINEERING AND TECHNICAL SUPPORT SERVICES CORPORATION (US) | 2024-03-21 | — | — | WO | claimed |
| EP-0602994-B1 | Corrosion inhibitor for iron-containing materials | EXXON RESEARCH ENGINEERING CO (US) | 1997-06-11 | — | — | EP | claimed |
| EP-0602994-A2 | Corrosion inhibitor for iron-containing materials | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1994-06-22 | — | — | EP | claimed |
| US-5279651-A | Inorganic/organic inhibitor for corrosion of iron containing materials in sulfur environment | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1994-01-18 | — | — | US | claimed |
| US-20230303905-A1 | ALKALINE EARTH METAL MINERALS AS CARRIERS FOR SURFACTANTS IN DRILLING FLUIDS | OMYA INTERNATIONAL AG (CH) | 2023-09-28 | — | — | US | disclosed |
| EP-4182399-A1 | ALKALINE EARTH METAL MINERALS AS CARRIERS FOR SURFACTANTS IN DRILLING FLUIDS | Omya International AG (CH) | 2023-05-24 | — | — | EP | disclosed |
| WO-2022013339-A1 | ALKALINE EARTH METAL MINERALS AS CARRIERS FOR SURFACTANTS IN DRILLING FLUIDS | OMYA INTERNATIONAL AG (CH) | 2022-01-20 | — | — | WO | disclosed |
| EP-2923734-B1 | PURINE ANALOGUES AND THEIR USE AS IMMUNOSUPPRESSIVE AGENTS | UNIV LEUVEN KATH (BE) | 2018-01-10 | — | — | EP | disclosed |
| US-9730944-B2 | Antiviral activity of novel bicyclic heterocycles | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2017-08-15 | — | — | US | disclosed |
| US-9573966-B2 | Anti-cancer activity of novel bicyclic heterocycles | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2017-02-21 | — | — | US | disclosed |
| EP-2616077-B1 | ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES | UNIV LEUVEN KATH (BE) | 2016-08-31 | — | — | EP | disclosed |
| US-20160030447-A1 | Antiviral Activity of Novel Bicyclic Heterocycles | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) | 2016-02-04 | — | — | US | disclosed |
| EP-1478649-A1 | NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESS FOR PREPARING THE SAME | LG Life Sciences Ltd. (KR) | 2004-11-24 | — | — | EP | disclosed |
| US-20030166922-A1 | Novel cephalosporin compounds and process for preparing the same | LG LIFE SCIENCES LTD. (KR) | 2003-09-04 | — | — | US | disclosed |
| WO-2003072582-A1 | NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESS FOR PREPARING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2003-09-04 | — | — | WO | disclosed |
| EP-0602994-B1 | Corrosion inhibitor for iron-containing materials | EXXON RESEARCH ENGINEERING CO (US) | 1997-06-11 | — | — | EP | disclosed |
| EP-0602994-A2 | Corrosion inhibitor for iron-containing materials | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1994-06-22 | — | — | EP | disclosed |
| EP-0602994-A2 | Corrosion inhibitor for iron-containing materials | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1994-06-22 | — | — | EP | disclosed |
| US-5279651-A | Inorganic/organic inhibitor for corrosion of iron containing materials in sulfur environment | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
| US-5279651-A | Inorganic/organic inhibitor for corrosion of iron containing materials in sulfur environment | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1994-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166922-A1 | Novel cephalosporin compounds and process for preparing the same | CTRC, CNDP2, PTMS | CA12 756/4885CA1 1134/4885CA2 382/4885 |
| US-20160030447-A1 | Antiviral Activity of Novel Bicyclic Heterocycles | RNASE1, HAVCR2, RNASEH1 | CA12 2516/4885CA1 2372/4885CA2 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.